首页> 外国专利> Diuretic and uricosuric imidazo-azole-acryl:amide derivs. - prepd. e.g. by condensation of imidazo-azole-carboxaldehyde or ketone deriv. with acetamide cpd.

Diuretic and uricosuric imidazo-azole-acryl:amide derivs. - prepd. e.g. by condensation of imidazo-azole-carboxaldehyde or ketone deriv. with acetamide cpd.

机译:利尿和尿酸的咪唑-唑-丙烯酸:酰胺衍生物。 -准备例如通过咪唑-唑-甲醛或酮的缩合反应而得。用乙酰胺cpd。

摘要

Imidazo-azoleacrylamide derivs. (I), their stereoisomeric enantiomers, diastereomers and Z/E isomers and their acid addn. salts are new. X is N or CH; Y is S, O, NH or N-alkyl; R1, R2 are H, opt. cyclic alkyl, alkenyl or opt. substd. alkynyl (akyl opt. interrupted by O, S, NH or N-(ar)alkyl), phenyl, naphthyl, furyl, thienyl, pyrimidyl, pyrazinyl, (iso)quinolyl or opt. substd. pyridyl ring or -S(O)n-alkyl (where n is 0-2), -NR'R" or -CO-R'"; R', R" are H, (ar)alkyl or aryl (alkyl opt. interrupted by O, S, NH or N-alkyl), or NR'R" is a 5-7 membered ring opt. having one or two of O, S and N; R'" is H, OH, alkyl, alkoxy, alkenyl(oxy) alkynyl, aralkyloxy, aryloxy or NR'R"; R3 is H, CF3 or alkyl; R4 is H, CN, halogen, NO2, S(O)n-alkyl (where n is 0-2), alkoxy, -CO-R'", or opt. cyclic alkyl, alkenyl or alkynyl alkyl opt. substd. by halogen, CN and/or interrupted by O, S, NH, N-(ar)alkyl or N-aryl); R5 is an amino gp. -N(R6)(R7) where (a) R6, R7 are H, aryl or opt. satd. (a)cyclic aliphatic hydrocarbon residue opt. interrupted and/or substd. (the alkyl gps. opt. linked to form a 5- to 7-membered opt. substd. rings; or (b) -N(R6)(R7) is a 3-8 membered opt. satd. ring opt. carries 1-2 further heteroatoms and/or 1-4 substituents from alkyl, halogen, aryl, aralkyl, alkoxycarbonyl hydroxyalkyl, alkoxyalkyl or CF3, or which is opt. condensed with opt. substd. aromatic ring. (I) are diuretics and saluretics and can be used as antihypertensives.
机译:咪唑-唑基丙烯酰胺衍生。 (I),它们的立体异构对映异构体,非对映异构体和Z / E异构体以及它们的酸。盐是新的。 X为N或CH; Y是S,O,NH或N-烷基; R1,R2为H,可选。环状烷基,烯基或优选。取代炔基(被O,S,NH或N-(ar)烷基间断的烷基),苯基,萘基,呋喃基,噻吩基,嘧啶基,吡嗪基,(异)喹啉基或opt。取代吡啶基环或-S(O)n-烷基(其中n为0-2),-NR'R“或-CO-R'”; R′,R″为H,(芳)烷基或芳基(被O,S,NH或N-烷基间断的烷基),或NR′R″为5-7元环。具有O,S和N之一或两个; R'”是H,OH,烷基,烷氧基,烯基(氧基)炔基,芳烷氧基,芳氧基或NR'R“; R3为H,CF3或烷基; R 4为H,CN,卤素,NO 2,S(O)n-烷基(其中n为0-2),烷氧基,-CO-R'-或优选为环状烷基,烯基或炔基烷基,优选地由卤素,CN和/或被O,S,NH,N-(芳)烷基或N-芳基中断); R5是氨基g.-N(R6)(R7)其中(a)R6,R7是H,芳基或视饱和(a)环脂肪烃残基(经中断和/或取代)(烷基gps。opt连接形成5至7元的opt。取代环;或(b)-N (R6)(R7)是一个3-8元的饱和饱和基团,带有1-2个其他杂原子和/或1-4个选自烷基,卤素,芳基,芳烷基,烷氧基羰基羟烷基,烷氧基烷基或CF3的取代基,或(1)是利尿剂和利尿剂,可用作降压药。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号